Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline
about
sameAs
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsbeta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosisAdvanced glycation end products in human optic nerve headAdvanced glycation: an important pathological event in diabetic and age related ocular diseaseIdentification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complexThe oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin.3-hydroxykynurenine-mediated modification of human lens proteins: structure determination of a major modification using a monoclonal antibody.Diabetes and mass spectrometry.From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Histochemical and immunocytochemical approaches to the study of oxidative stress.Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleuInvolvement of Maillard reactions in Alzheimer disease.Advanced Maillard reaction end products are associated with Alzheimer disease pathologyAssociation between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA StudyAdvanced glycation end products up-regulate gene expression found in diabetic glomerular disease.Formation and reduction of acrylamide in Maillard reaction: a review based on the current state of knowledge.Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies.Pathways of the Maillard reaction under physiological conditions.Antioxidant status in J774A.1 macrophage cell line during chronic exposure to glycated serum.Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes.A novel aromatic mutagen, 5-amino-6-hydroxy-8H-benzo[6,7]azepino[5,4,3-de]quinolin-7-one (ABAQ), induces colonic preneoplastic lesions in miceImmunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes.Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease.N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.Glomerulosclerosis in captive cheetahs (Acinonyx jubatus).The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic PNonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies.Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells.Probing Protein Glycation by Chromatography and Mass Spectrometry: Analysis of Glycation Adducts.Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
P2860
Q24561776-83600BCD-1579-40F3-A419-0FE123DE2E21Q24597379-F7C679D1-A2CE-4057-96F8-2E73ECC0776FQ28345352-A6BD3257-E9FF-4BFF-A168-C03908E944B9Q28365776-22DFC088-6EC4-420E-B901-9CC81050F29DQ28577438-1B7C22C5-D659-4222-80C0-4634CD819E9DQ30328108-D1CB5789-2368-4FC7-B2A5-95C375E254A1Q30986731-4AD42216-F36C-4F3E-A5FF-77169ACAB8EDQ30986952-8BAAB64E-AC22-41C6-B289-5765E194B239Q33220108-810DFE80-395E-4834-A77E-9B6901627B54Q33793187-B046BCA9-78B7-4E1B-8878-86D58B23981FQ33931285-02103770-85DF-423E-A2FC-08226DD32DC9Q34111608-23685317-F59D-4810-8F04-32E812274A58Q34124460-52528268-0744-47B6-936A-6BB84DBFA7DDQ35164047-CB6595B8-B1E4-43BA-9245-EC68EC4C5DA7Q35527031-B737D410-46F0-47F4-A552-8BF025E2CCD2Q35644178-852459E7-0D19-4E15-BD1B-29003E2D718BQ35788094-D179D779-118C-49F3-8224-F23621645214Q36844858-DAF80680-6C1F-405B-A8EE-6D0ECF2798ADQ37348615-CAFB6E47-ED26-4A3D-8CF6-260C11A78BDBQ37363088-0CF64BC3-F67C-47D0-A25F-AAD8CA3BE3CEQ37376119-8D07FCC5-198D-4742-9C21-84ABB8835F7AQ38151611-1A50B614-D3DF-4E66-ADCD-CC6E6B1F8E2CQ38862611-C62232EF-8829-4B90-A149-C59EF9615CBBQ40428494-34844193-D3C2-45D4-A032-6FBFFC46B82EQ40789140-4DBCE7DD-C1B4-49B7-B3C4-9C096D33F4F7Q41127916-09F43FC0-A13B-481C-B501-FB88B04EDF45Q41681546-558805DC-C0DA-4876-8369-49666CEDC663Q42544383-59BC51B3-895A-4F8E-AC8C-E87ACBA71C63Q43219671-6FEAC63F-E65D-4696-9398-A5A5FC6B86A2Q43718267-31805AE7-3754-49FD-89F9-5787DCAF7A0CQ44125361-86125D91-E5CF-41D5-9E2E-EAA979D6E16BQ44648415-6B642A31-2BC7-4FA8-A341-25749AD4BA51Q44844852-6C75E1CD-E37A-40F8-A42A-322A8A95AA09Q46613107-2DDB1175-245B-4137-B79E-047BC8E7CFBFQ47340371-6A4BE6D4-AA05-453E-8419-7DC5A3551E82Q54126440-E15592E7-E48B-4297-B4E0-79AA22DA115F
P2860
Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Immunohistochemical detection ...... noclonal antibody to pyrraline
@ast
Immunohistochemical detection ...... noclonal antibody to pyrraline
@en
Immunohistochemical detection ...... noclonal antibody to pyrraline
@nl
type
label
Immunohistochemical detection ...... noclonal antibody to pyrraline
@ast
Immunohistochemical detection ...... noclonal antibody to pyrraline
@en
Immunohistochemical detection ...... noclonal antibody to pyrraline
@nl
prefLabel
Immunohistochemical detection ...... noclonal antibody to pyrraline
@ast
Immunohistochemical detection ...... noclonal antibody to pyrraline
@en
Immunohistochemical detection ...... noclonal antibody to pyrraline
@nl
P2860
P921
P356
P1476
Immunohistochemical detection ...... noclonal antibody to pyrraline
@en
P2093
P2860
P304
P356
10.1172/JCI115690
P407
P577
1992-04-01T00:00:00Z